Paris - Delayed Quote EUR

Theraclion SA (ALTHE.PA)

0.1435

-0.0012

(-0.83%)

At close: April 11 at 5:13:26 PM GMT+2

Theraclion Completes Its Previous Financing Round With an Additional Convertible Bonds Issuance

MALAKOFF, France, March 26, 2025--Regulatory News: This press release must not be published, distributed, or disseminated, directly or indirectly, in the United Kingdom, the United States of America, Australia, Canada, or Japan.

Business Wire 18 days ago

TCLIF
Theraclion Secures Financing From Its Historical Shareholders Through a Convertible Bond Loan

MALAKOFF, France, February 20, 2025--Regulatory News: This press release must not be published, distributed, or disseminated, directly or indirectly, in the United Kingdom, the United States of America, Australia, Canada, or Japan.

Business Wire last month

TCLIF
Theraclion Announces Treatment of First Patients With New SONOVEIN® ‘SpeedPulse’ Feature Accelerating Treatment

MALAKOFF, France, February 11, 2025--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces today that its latest generation SONOVEIN® ‘SpeedPulse’ feature is being tried on patients.

Business Wire last month

TCLIF
Theraclion: Publication of Adjusted Accounts for the First Half of 2024

MALAKOFF, France, February 07, 2025--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy for the treatment of varicose veins, reports on its 2024 activities.

Business Wire 2 months ago

TCLIF
Theraclion Reviews Its 2024 Achievements

MALAKOFF, France, January 06, 2025--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy for the treatment of varicose veins, reports on its 2024 activities.

Business Wire 3 months ago

TCLIF
Theraclion Announces Major Advances and Reports First-Half Financial Results

MALAKOFF, France, October 30, 2024--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy for the treatment of varicose veins, reports on the implementation of its strategy for the first half of 2024 and the start of its commercial ramp-up.

Business Wire 5 months ago

TCLIF
Theraclion Confirms Strong Mid-Year Achievements

MALAKOFF, France, September 06, 2024--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, provides an update on the key achievements in execution of its strategy for the first half of 2024.

Business Wire 7 months ago

TCLIF
SONOVEIN® FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule

MALAKOFF, France, June 24, 2024--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE) innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces today that treatments in the United States’ FDA (Food & Drug Administration) pivotal study for SONOVEIN® have concluded, in accordance with the scheduled timeline.

Business Wire 9 months ago

TCLIF
Theraclion: SONOVEIN® Highlighted in Top Medical Conferences and Scientific Journal

MALAKOFF, France, June 06, 2024--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces that its cutting-edge technology to treat varicose veins has recently been showcased at a number of prestigious medical conferences and in a new scientific journal:

Business Wire 10 months ago

TCLIF

Performance Overview

Return	ALTHE.PA	CAC 40 (^FCHI)
YTD	-56.65%	-3.74%
1-Year	-61.22%	-11.45%
3-Year	-88.92%	+8.37%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Theraclion SA (ALTHE.PA)

Theraclion Completes Its Previous Financing Round With an Additional Convertible Bonds Issuance

Theraclion Secures Financing From Its Historical Shareholders Through a Convertible Bond Loan

Theraclion Announces Treatment of First Patients With New SONOVEIN® ‘SpeedPulse’ Feature Accelerating Treatment

Theraclion: Publication of Adjusted Accounts for the First Half of 2024

Theraclion Reviews Its 2024 Achievements

Theraclion Announces Major Advances and Reports First-Half Financial Results

Theraclion Confirms Strong Mid-Year Achievements

SONOVEIN® FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule

Theraclion: SONOVEIN® Highlighted in Top Medical Conferences and Scientific Journal

Performance Overview